Hepatitis B virus (HBV) co-infection with human immunodeficiency virus is a major public health problem especially in developing countries. In a descriptive study, the prevalence of HBsAg and HBV serotypes using antigen detection and PCR methods were evaluated among HIV patients accessing healthcare in a Tertiary Healthcare Facility in Central Nigeria. After ethical clearance, blood samples were aseptically collected between January to April 2016 from 547 subjects who gave informed consent and completed self-administered questionnaire. Blood samples were analyzed using HBsAg screening kit (ACON Laboratories Inc, USA) and Nested PCR approach. The Chi-square statistical test was performed to identify possible risk factors associated with the viral seropositivity. Overall, 53 (9.7%) had IgG antibodies against HBV. A higher prevalence of Short Research Article
Infections of Hepatitis B and C viruses among seropositive Human immunodeficiency virus patients are a growing public health problem in Sub Saharan Africa characterized by unaffordable treatment, severe morbidity and associated mortality. This study was aimed at evaluating the seroprevalence of Hepatitis B and C viruses among HIV infected patients accessing health care at Federal Medical Centre, Keffi, Nigeria. The cross-sectional study took place between May-July 2016. A total of 200 blood samples were collected from HIV patients after informed consent and self-administered questionnaires were completed. The samples were centrifuged and the serum screened for HBV and HCV using the immunochromatographic technique. A general prevalence of infection with hepatitis B and C viruses in the study population was 17.5%. The prevalence of HBV infection was 12.5% while HCV was 5.0%. Females have higher infection rates for both viruses (p > 0.05). HBV infection was highest among those aged 20-29 years (14.3%) and lowest among those aged 30-39 years (6.5%). HCV infection was highest among those aged > 40 years (8.7%)
This study aimed to evaluate the prevalence of Entamoeba histolytica infection using microscopy and adhesin detection methods among school children in Central Nigeria. After ethical clearance, stool samples of three hundred and sixty (360) children aged 5-16 years old as adopted by FMOH (2013) were randomly collected between September-December 2015 and were examined for E. histolytica cysts/trophozoites using microscopy and TechLab E. histolytica II ELISA test (Sigma Diagnostic Inc, USA) in six public primary schools in Keffi, Nasarawa State. The TechLab E. histolytica II ELISA result showed that out of the 88 (24.4%) stool samples positive by microscopy, 85 (96.6%) samples were positive for E. histolytica antigens while 3 (3.4%) were negative. The overall prevalence of the infection using microscopy method was 24.4%. Males recorded a higher prevalence 64 (30.5%) than females 24 (16.0%). Children aged 6-10 years recorded the highest prevalence of 37 (28.5%) while the lowest 22 (21.6%) was showed in those aged <6 years. There was significant difference in the infection rate among the sex of the children (p≤ 0.05). The association was also significant based on location of the children's homes and finger sucking habit. Short Research Article Children living outside Keffi town had a higher prevalence 34 54 (23.9%). Out of the children infected, 23 this study age, pupil's class, occupations of facility had no statistical significance with programmes that will promote personal and environmental hygiene and regular mass treatment are suggested strategies to mitigate transmission of the infection especially in children who are usually asymptomatic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.